| II-37 Victor Mangas-Sanjuan Population Pharmacokinetic and exposure-efficacy Markov modelling of enzymatic activity in Gaucher disease patients treated with enzyme replacement therapy Wednesday 15:10-16:40 |
| II-37 Victor Mangas-Sanjuan Population Pharmacokinetic and exposure-efficacy Markov modelling of enzymatic activity in Gaucher disease patients treated with enzyme replacement therapy Wednesday 15:10-16:40 |